ompson, M DF i gu re 2. High I}(III -c r shows plasma cells (eccentrically located nuclei ) and lvmpliocvt cs dest royin g tlu:ca rtilage plate. There is cu rtilage disso lution and a decrea se in the amo unt oftlu:lacunar spaces.
cochlear damage. and (8) vestibular damage. Relapsing polychondritis is associated with other immunologically mediated diseases. such as sys temic lupus erythematosus. rheumatoid arthritis. and Sjog ren' s syndrome.
Although gross findi ngs are nonspecific. relapsing polychondritis is characterized by an overall thickeni ng of the cartilage of the ear. nose. epiglottis. and cricoid and trachea l rings. The cartilage loses its basophilic quality (blue) and becomes more eos inophilic (red) as the disorder progresses. Fragmentation of the cartilage results in necrosis and lysis of the cartilaginous plates. The outer perichondrium (lining of cartilage) is permeated by a spectrum of inflamm atory ce lls. including neut roph ils. eosinophils. lymphocytes. and plasma cells (figures I and 2): these changes are frequently associated with ede ma or gelatinous cystic degeneration. As the disease progresses. the degenerated fibrillar cartilage imperceptibly blends with the surrounding inflammatory ce lls. leading to the formation of granulation-type tissue and fibrosis.
In making a diagnosis. it is necessary to exc lude other diseases. including sarco idos is. infection (e.g.. tuberculosis. syphilis. and various fungal. bacterial. and viral infections). lymph oma. and Wegener' s granulomatosis. Obtaining cultures or performing histochemi cal staining can help rule out infectious organisms. while clinical tests for cartilage matrix proteins or antibodies to type II co llage n (found uniquely in cartilage) can help define relapsing polychondr itis. Patients should be treated with either a corticosteroid or an immunosuppr essive agent. depending on the severity of the disease. 
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